Trending
A systematic review links astaxanthin to lower inflammatory markers IL-6 and TNF-α — but the evidence comes entirely from clinical populations, not general wellness seekers.
This is the first indexed systematic review on astaxanthin for inflammation, so the signal is real but narrow — it's seen in people with existing health conditions, and the picture for healthy adults is still an open question.
The review pooled studies where people with various health issues took astaxanthin, and it consistently found drops in inflammatory messengers (IL-6, TNF-α) and oxidative stress, along with rises in the body's own antioxidant defenses (SOD, TAC). The same studies also reported improvements in metabolism, blood lipids, and body composition — but every participant was in a clinical setting, so we can't assume the same effects in generally healthy people without further research.
Where this fits in the evidence
This is among the first studies we've indexed on Astaxanthin for Reduced Pro-Inflammatory Cytokines — treat it as an early signal until more research accumulates.
The study
- Systematic Review
- 2026-01-09
- International journal of molecular sciences
- PubMed: 41596351
- DOI: 10.3390/ijms27020700
- Full study breakdown →
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.